| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-07 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0004 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.001 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.19 | 0.001 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.087 | 0.001 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.003 |